The structural basis of phenylketonuria

Molecular Genetics and Metabolism

Volumn 68, Issue 2, 1999, Pages 103-125

  Erlandsen, Heidi ^a   Stevens, Raymond C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Hyperphenylalaninemia; Phenylalanine hydroxylase; Phenylketonuria; Structure function relationship

Indexed keywords

PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; TETRAHYDROBIOPTERIN; TYROSINE;

AUTOSOMAL RECESSIVE DISORDER; CRYSTAL STRUCTURE; DELETION MUTANT; ENZYME DEFICIENCY; ENZYME STRUCTURE; GENE INSERTION; GENE MUTATION; HYPERPHENYLALANINEMIA; NUCLEOTIDE SEQUENCE; PHENYLKETONURIA; POINT MUTATION; PRIORITY JOURNAL; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

EID: 0032711431     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2922     Document Type: Article

References (89)

1. Kaufman S. The phenylalanine hydroxylating system. Adv Enzymol. 70:1993;77-264.
2. Kappock T J, Caradonna J P. Pterin-dependent amino acid hydroxylases. Chem Rev. 96:1996;2659-2756.
3. Hufton S E, Jennings I G, Cotton R GH. Structure and function of the aromatic amino acid hydroxylases. Biochem J. 311:1995;353-366.
4. Waters P J, Parniak M A, Nowacki P, Scriver C R. In vitro expression analysis of mutations in phenylalanine hydroxylase: Linking genotype to phenotype and structure to function. Hum Mutat. 11:1998;4-17.
5. Scriver C R, Kaufman S, Eisensmith R C, Woo S LC. The hyperphenylalaninemias. Scriver C R, Beaudet A L, Sly W S, Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;1015-1075 McGraw-Hill, New York.
6. Hoang L, Byck S, Prevost L, Scriver C R. PAH Mutation Analysis Consortium Database: A database for disease-producing and other allelic variations at the human PAH locus. Nucleic Acids Res. 24:1996;127-131.
7. Nowacki P, Byck S, Prevost L, Scriver C S. The PAH mutation analysis consortium database: Update 1996. Nucleic Acids Res. 25:1997;139-142.
8. Nowacki P, Byck S, Prevost L, Scriver C R. PAH Mutation Analysis Consortium Database: 1997. Prototype for relational locus-specific mutation databases. Nucleic Acids Res. 26:1998;220-225.
9. Erlandsen H, Fusetti F, Martinez A, Hough E, Flatmark T, Stevens R C. Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. Nature Struct Biol. 4:1997;995-1000.
10. Fusetti F, Erlandsen H, Flatmark T, Stevens R C. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J Biol Chem. 273:1998;16962-16967.
11. Kobe B, Jennings I G, House C M, Michell B J, Goodwill K E, Santarsiero B D, Stevens R C, Cotton R GH, Kemp B E. Structural basis of autoregulation of phenylalanine hydroxylase. Nature Struct Biol. 6:1999;442-448.
12. Goodwill K E, Sabatier C, Stevens R C. Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2. 3A resolution: Self-hydroxylation of Phe300 and the pterin-binding site. Biochemistry. 37:1998;13437-13445.
13. Martinez A, Knappskog P M, Olafdottir S, Døskeland A P, Eiken H G, Svebak R M, Bozzini M, Apold J, Flatmark T. Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Biochem J. 306:1995;589-597.
14. Flatmark T, Knappskog P M, E, Martinez A. Molecular characterization of disease related mutant forms of human phenylalanine hydroxylase and tyrosine hydroxylase. Pfleiderer W Rokos H. Chemistry and Biology of Pteridines and Folates. 1997;503-508 Blackwell Science, London.
15. Cooper D N, Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease; patterns and predictions. Hum Genet. 85:1990;55-74.
16. Jennings I G, Kemp B E, Cotton R GH. Localization of cofactor binding sites with monoclonal anti-idiotype antibodies: phenylalanine hydroxylase. Proc Natl Acad Sci USA. 88:1991;5734-5738.
17. Knappskog P M, Eiken H G, Martinez A, Bruland O, Apold J, Flatmark T. PKU mutation (D143G) associated with an apparent high residual enzyme activity: Expression of a kinetic variant form of phenylalanine hydroxylase in three different systems. Hum Mutat. 8:1996;236-246.
18. Bjørgo E, Knappskog P M, Martinez A, Stevens R C, Flatmark T. Partial characterization and three-dimensional-structural localization of eight mutations in exon 7 of the human phenylalanine hydroxylase gene associated with phenylketonuria. Eur J Biochem. 257:1998;1-10.
19. Okano Y, Eisensmith R C, Guttler F, Lichter-Konecki U, Konecki D S, Trefz F K, Dasovich M, Wang T, Henriksen K, Lou H. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 324:1991;1232-1238.
20. Knappskog P M, Eiken H G, Martinez A, Olafsdottir S, Haavik J, Flatmark T, Apold J. Expression of wild-type and mutant forms of human phenylalanine hydroxylase in E. coli. Ayling J E. Chemistry and Biology of Pteridines and Folates. 1993;59-62 Plenum Press, New York.
21. Baric I, Mardesic D, Sarnavoka V, Lichter-Konecki U, Konecki D S, Trefz F K. Geographical distribution of the P281L mutation at the phenylalanine hydroxylase locus: Possible origin in southeastern Europe. J Inherit Metab Dis. 7:1994;376-377.
22. Dworniczak B, Grudda K, Stumper J, Bartholome K, Aulehla-Scholz C, Horst J. Phenylalanine hydroxylase gene: Novel missense mutation in exon 7 causing severe phenylketonuria. Genomics. 9:1991;193-199.
23. Okano Y, Wang T, Eisensmith R C, Longhi R, Riva E, Giovannini M, Cerone R, Romano C, Woo S L. Phenylketonuria missense mutations in the Mediterranean. Genomics. 9:1991;96-103.
24. Benit P, Rey F, Melle D, Munnich A, Rey J. Five novel missense mutations of the phenylalanine hydroxylase gene in phenylketonuria. Hum Mutat. 4:1994;229-231.
25. Guldberg P, Levy H L, Hanley W B, Koch R, Matalon R, Rouse B M, Trefz F, de la Cruz F, Henriksen K F, Guttler F. Phenylalanine hydroxylase gene mutations in the United States: Report from the Maternal PKU Collaborative Study. Am J Hum Genet. 59:1996;84-94.
26. Knappskog P M, Eiken H G, Martinez A, Flatmark T, Apold J. The PKU mutation S349P causes complete loss of catalytic activity in the recombinant phenylalanine hydroxylase enzyme. Hum Genet. 95:1995;171-173.
27. De Lucca M, Perez B, Desviat L R, Ugarte M. Molecular basis of phenylketonuria in Venezuela: Presence of two novel null mutations. Hum Mutat. 11:1998;354-359.
28. Eiken H G, Knappskog P M, Boman H, Thune K S, Kaada G, Motzfeldt K, Apold J. Relative frequency, heterogeneity, and geographic clustering of PKU mutations in Norway. Eur J Hum Genet. 4:1996;205-213.
29. John S WM, Scriver C R, Laframboise R, Rozen R. In vitro and in vivo correlations for I65T and M1V mutations at the phenylalanine hydroxylase locus. Hum Mutat. 1:1992;147-153.
30. Waters P J, Parniak M A, Hewson A S, Scriver C R. Alterations in protein aggregation and degradation due to mild and severe missense mutations (A104D, R157N) in the human phenylalanine hydroxylase gene (PAH). Hum Mutat. 12:1998;344-354.
31. Okano Y, Wang T, Eisensmith R C, Steinmann B, Gitzelmann R, Woo S L. Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet. 46:1990;18-25.
32. Wang T, Okano Y, Eisensmith R C, Lo W H, Huang S Z, Zeng Y T, Yuan L F, Liu S R, Woo S L. Missense mutations prevalent in Orientals with phenylketonuria: Molecular characterization and clinical implications. Genomics. 10:1991;449-456.
33. Svensson E, von Dobeln U, Eisensmith R C, Hagenfeldt L, Woo S L. Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur J Pediatr. 152:1993;132-139.
34. DiLella A G, Marvit J, Brayton K, Woo S L. An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. Nature. 327:1987;333-336.
35. Svensson E, Eisensmith R C, Dworniczak B, von Dobeln U, Hagenfeldt L, Horst J, Woo S L. Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12. Hum Mutat. 1:1992;129-137.
36. Tyfield L A, Stephenson A, Cockburn F, Harvie A, Bidwell J L, Wood N A, Pilz D T, Harper P, Smith I. Sequence variation at the phenylalanine hydroxylase gene in the British Isles. Am J Hum Genet. 60:1997;388-396.
37. Perez B, Desviat L R, De Lucca M, Ugarte M. Spectrum and origin of phenylketonuria mutations in Spain. Acta Paediatr Suppl. 407:1994;34-36.
38. Mallolas J, Campistol J, Lambruschini N, Vilaseca M A, Cambra F J, Estivill X, Mila M. Two novel mutations in exon 11 of the PAH gene (V1163del TG and P362T) associated with classic phenylketonuria and mild phenylketonuria. Hum Mutat. 11:1998;482.
39. Guldberg P, Henriksen K F, Guttler F. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics. 17:1993;141-146.
40. Caillaud C, Lyonnet S, Rey F, Melle D, Frebourg T, Berthelon M, Vilarinho L, Vaz Osorio R, Rey J, Munnich A. A 3-base pair in-frame deletion of the phenylalanine hydroxylase gene results in a kinetic variant of phenylketonuria. J Biol Chem. 266:1991;9351-9354.
41. DiLella A G, Marvit J, Lidsky A S, Guttler F, Woo S LC. Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. Nature. 322:1986;799-803.
42. Marvit J, DiLella A G, Brayton K, Ledley F D, Robson K J, Woo S L. GT to AT transition at a splice donor site causes skipping of the preceding exon in phenylketonuria. Nucleic Acids Res. 15:1987;5613-5628.
43. Kabsch W, Sander C. Dictionary of protein secondary structure:pattern recognition of hydrogen bonded and geometrical features. Biopolymers. 22:1983;2577-2637.
44. Kayaalp E, Treacy E, Waters P J, Byck S, Nowacki P, Scriver C R. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: A metanalysis of genotype-phenotype correlations. Am J Hum Genet. 61:1997;1309-1317.
45. Forrest S M, Dahl H H, Howells D W, Dianzani I, Cotton R G. Mutation detection in phenylketonuria by using chemical cleavage of mismatch: Importance of using probes from both normal and patient samples. Am J Hum Genet. 49:1991;175-183.
46. Carter K C, Rozen R, Byck S, Scriver C R. Novel mutations and heterogeneity of the phenylalanine hydroxylase (PAH) gene on Quebec PKU chromosomes. Am J Hum Genet. 57:1995;A161.
47. Guldberg P, Henriksen K F, Thony B, Blau N, Guttler F. Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patients. Genomics. 21:1994;453-455.
48. Lichter-Konecki, U, Schlotter, M, Trefz, F, K, Konecki, D, S, Identification of the new mutations at the phenylalanine hydroxylase gene locus. Vth International Congress Inborn Errors of Metabolism W4.4, 1990, (abstract).
49. Li J, Eisensmith R C, Wang T, Lo W H, Huang S Z, Zeng Y T, Yuan L F, Liu S R, Woo S L. Phenylketonuria in China: Identification and characterization of three novel nucleotide substitutions in the human phenylalanine hydroxylase gene. Hum Mutat. 3:1994;312-314.
50. Bosco P, Cali F, Meli C, Mollica F, Zammarchi E, Cerone R, Vanni C, Palillo L, Greco D, Romano V. Eight new mutations of the phenylalanine hydroxylase gene in Italian patients with hyperphenylalaninemia. Hum Mutat. 11:1998;240-243.
51. Horst J, Eigel A, Auleha-Scholz C, Kalaydjieva L, Zygulska M, Kunert E, Dworniczak B. Molecular basis of phenylketonuria: Report of an extensive study of various Caucasian populations. Am J Hum Genet. 49:1991;A2302.
52. Eisensmith R C, Martinez D, Kuzmin A, Goltsov A, Woo S LC. Molecular basis of phenylketonuria in a heterogeneous US population (Abstract). Am J Hum Genet. 57:1995;A163.
53. Perez B, Desviat L R, Ugarte M. Analysis of the phenylalanine hydroxylase gene in the Spanish population: Mutation profile and association with intragenic polymorphic markers. Am J Hum Genet. 60:1997;95-102.
54. Ramus S J, Treacy E P, Cotton R G. Characterization of phenylalanine hydroxylase alleles in untreated phenylketonuria patients from Victoria, Australia: Origin of alleles and haplotypes. Am J Hum Genet. 56:1995;1034-1041.
55. Li J, Eisensmith R C, Wang T, Lo W H, Huang S Z, Zeng Y T, Yuan L F, Liu S R, Woo S L. Identification of three novel missense PKU mutations among Chinese. Genomics. 13:1992;894-895.
56. Takarada Y, Kalanin J, Yamashita K, Ohtsuka N, Kagawa S, Matsuoka A. Phenylketonuria mutant alleles in different populations: Missense mutation in exon 7 of phenylalanine hydroxylase gene. Clin Chem. 39:1993;2354-2355.
57. Shirahase W, Shimada A M. Genetic study on Japanese classical phenylketonuria (family analysis by PCR-SSCP analysis). Acta Pediatr Japan. 96:1992;939-945.
58. Goltsov A, Kouzmine A, Eisensmith R C, Effat L, Tempamy S, Rushdi S, Abdel-Meguid N, Woo S LC. Molecular basis of phenylketonuria in Egypt (abstract). Am J Hum Genet. 55:1994;1288.
59. Kuzmin A I, Eisensmith R C, Goltsov A A, Sergeeva N A, Schwartz E I, Woo S L. Complete spectrum of PAH mutations in Tataria: Presence of Slavic, Turkic and Scandinavian mutations. Eur J Hum Genet. 3:1995;246-255.
60. Zschocke J, Graham C A, Stewart F J, Carson D J, Nevin N C. Non-phenylketonuria hyperphenylalaninaemia in Northern Ireland: Frequent mutation allows screening and early diagnosis. Hum Mutat. 4:1994;114-118.
61. van der Sijs-Bos C J, Diepstraten C M, Juyn J A, Plaisier M, Giltay J C, van Spronsen F J, Smit G P, Berger R, Smeitink J A, Poll-The B T, Ploos van Amstel J K. Phenylketonuria in The Netherlands: 93% of the mutations are detected by single-strand conformation analysis. Hum Hered. 46:1996;185-190.
62. Hashem N, Bosco P, Chiavetta V, Cali F, Ceratto N, Romano V. Preliminary studies on the molecular basis of hyperphenylalaninemia in Egypt. Hum Genet. 98:1996;3-6.
63. Popescu A, Andrian T, Guttler F, Guldberg P. Genotype-phenotype correlation in 11 Romanian PKU families. J Inherit Metab Dis. 17:1994;374-375.
64. Dianzani I, Giannattasio S, de Sanctis L, Alliaudi C, Lattanzio P, Vici C D, Burlina A, Burroni M, Sebastio G, Carnevale F. Characterization of phenylketonuria alleles in the Italian population. Eur J Hum Genet. 3:1995;294-302.
65. Dworniczak B, Kalaydjieva L, Pankoke S, Aulehla-Scholz C, Allen G, Horst J. Analysis of exon 7 of the human phenylalanine hydroxylase gene: A mutation hot spot? Hum Mutat. 1:1992;138-146.
66. Zschocke J, Graham C A, Carson D J, Nevin N C. Phenylketonuria mutation analysis in Northern Ireland: A rapid stepwise approach. Am J Hum Genet. 57:1995;1311-1317.
67. Okano Y, Hase Y, Lee D H, Takada G, Shigematsu Y, Oura T, Isshiki G. Molecular and population genetics of phenylketonuria in Orientals: Correlation between phenotype and genotype. J Inherit Metab Dis. 17:1994;156-159.
68. Perez B, Desviat L R, Ugarte M. Expression analysis of mutation P244L, which causes mild hyperphenylalaninemia. Hum Mutat. 5:1995;188-190.
69. Caillaud C, Vilarinho L, Vilarinho A, Rey F, Berthelon M, Santos R, Lyonnet S, Briard M L, Osorio R V, Rey J. Linkage disequilibrium between phenylketonuria and RFLP haplotype 1 at the phenylalanine hydroxylase locus in Portugal. Hum Genet. 89:1992;69-72.
70. Shirahase W, Oya N, Shimada M. A new single base substitution in a Japanese phenylketonuria (PKU) patient. Brain Dev. 13:1991;283-284.
71. Leandro, P, Rivera, I, Ribeiro, V, Tavares de Almeida, I, Lechner, M, C, Sequencing analysis of PAH genomic DNA reveals 4 novel mutations affecting exons 7 and 11 in a Portugese PKU population. Abstr. SSIEM, Manchester, 1993.
72. Kleiman S, Li J, Schwartz G, Eisensmith R C, Woo S L, Shiloh Y. Inactivation of phenylalanine hydroxylase by a missense mutation, R270S, in a Palestinian kinship with phenylketonuria. Hum Mol Genet. 2:1993;605-606.
73. Melle D, Verelst P, Rey F, Berthelon M, Francois B, Munnich A, Lyonnet S. Two distinct mutations at a single BamHI site in phenylketonuria. J Med Genet. 28:1991;38-40.
74. Goebel-Schreiner B, Schreiner R. Identification of a new missense mutation in Japanese phenylketonuric patients. J Inherit Metab Dis. 16:1993;950-956.
75. Labrune P, Melle D, Rey F, Berthelon M, Caillaud C, Rey J, Munnich A, Lyonnet S. Single-strand conformation polymorphism for detection of mutations and base substitutions in phenylketonuria. Am J Hum Genet. 48:1991;1115-1120.
76. Takahashi K, Masamune A, Kure S, Matsubara Y, Narisawa K. Ectopic transcription: An application to the analysis of splicing errors in phenylalanine hydroxylase mRNA. Acta Paediatr Suppl. 407:1994;45-46.
77. Zygulska M, Eigel A, Pietrzyk J J, Horst J. Phenylketonuria in southern Poland: A new splice mutation in intron 9 at the PAH locus. Hum Mutat. 4:1994;297-299.
78. Eisensmith R C, Woo S L. Molecular basis of phenylketonuria and related hyperphenylalaninemeias: Mutations and polymorphisms in the human phenylalanine gene. Hum Mutat. 1:1992;13-23.
79. Kalaydjieva L, Dworniczak B, Kremensky I, Koprivarova K, Radeva B, Milusheva R, Aulehla-Scholz C, Horst J. Heterogeneity of mutations in Bulgarian phenylketonuria haplotype 1 and 4 alleles. Clin Genet. 41:1992;123-128.
80. Economou-Petersen E, Henriksen K F, Guldberg P, Guttler F. Molecular basis for nonphenylketonuria hyperphenylalaninemia. Genomics. 14:1992;1-5.
81. Rozen R, Mascisch A, Lambert M, Laframboise R, Scriver C R. Mutation profiles of phenylketonuria in Quebec populations: Evidence of stratification and novel mutations. Am J Hum Genet. 55:1994;321-326.
82. Lichter-Konecki U, Konecki D S, DiLella A G, Brayton K, Marvit J, Hahn T M, Trefz F K, Woo S L. Phenylalanine hydroxylase deficiency caused by a single base substitution in an exon of the human phenylalanine hydroxylase gene. Biochemistry. 27:1988;2881-2885.
83. Weinstein M, Eisensmith R C, Abadie V, Avigad S, Lyonnet S, Schwartz G, Munnich A, Woo S L, Shiloh Y. A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria. Hum Genet. 90:1993;645-649.
84. Desviat L R, Perez B, De Lucca M, Cornejo V, Schmidt B, Ugarte M. Evidence in Latin America of recurrence of V388M, a phenylketonuria mutation with high in vitro residual activity. Am J Hum Genet. 57:1995;337-342.
85. Desviat L R, Perez B, Ugarte M. Molecular basis of non-PKU hyperphenylalaninaemia in Spain: Prevalence of A403V, a mutation with high residual activity. J Inherit Metab Dis. 19:1996;227-230.
86. Wang T, Okano Y, Eisensmith R C, Harvey M L, Wilson H YL, Huang S-Z, Zeng Y-T, Yuan L-F, Furuyama J-I, Oura T, Sommer S S, Woo S LC. Founder effect of a prevalent phenylketonuria mutation in the Oriental population. Proc Natl Acad Sci USA. 88:1991;2146-2150.
87. Sullivan S E, Lidsky A S, Brayton K, DiLella A G, King M, Connor M, Cockburn F, Woo S LC. Phenylalanine hydroxylase deletion mutant from a patient with classical PKU. Am J Hum Genet. 37:1985;A177.
88. Kleiman S, Bernstein J, Schwartz G, Eisensmith R C, Woo S L, Shiloh Y. A defective splice site at the phenylalanine hydroxylase gene in phenylketonuria and benign hyperphenylalaninemia among Palestinian Arabs. Hum Mutat. 1:1992;340-343.
89. Avigad S, Cohen B E, Bauer S, Schwartz G, Frydman M, Woo S L, Niny Y, Shiloh Y. A single origin of phenylketonuria in Yemenite Jews. Nature. 344:1990;168-170.